{"id":"W2980707925","doi":"10.1177/2055217319879952","title":"Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Chugai Pharmaceutical; Multiple Sclerosis Society of Canada; Acorda Therapeutics; EMD Serono; Vancouver Coastal Health Research Institute; Michael Smith Health Research BC; Vertex Pharmaceuticals; Multiple Sclerosis Society; Sanofi Genzyme; F. Hoffmann-La Roche; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Ocrelizumab; Gliosis; Medicine; Interferon beta; Magnetic resonance imaging; Multiple sclerosis; Internal medicine; Oncology; Nuclear magnetic resonance; Immunology; Pathology; Radiology; Physics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000463708,0.0001679758,0.0005135072,0.0002275314,0.00020212,0.0002573306,0.0001396887,0.0003992243,0.001131712],"category_scores_gemma":[0.001038745,0.0001134268,0.0002369222,0.0001441765,0.0001762349,0.0001909324,0.0001125375,0.0003617145,0.000169659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002384626,"about_ca_system_score_gemma":0.0001503224,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006802074,"about_ca_topic_score_gemma":0.0007826608,"domain_scores_codex":[0.9998659,0.00003311969,0.00001853935,0.0000334844,0.00001989057,0.00002893118],"domain_scores_gemma":[0.9993606,0.0001244485,0.0002348097,0.00003874481,0.0000750469,0.0001662915],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.07283049,0.00158181,0.7835613,0.0001463165,0.0005231571,0.001730504,0.0005425665,0.0003869081,0.09207137,0.00005212871,0.0004506456,0.04612284],"study_design_scores_gemma":[0.0006471824,0.01245881,0.9818751,0.00001442589,0.0001887511,0.001180929,0.0001671088,0.0002326039,0.002754833,0.00004023531,0.0004314436,0.00000841567],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994486,0.0002605391,0.00001567416,0.00002479671,0.000003585869,0.000004976767,0.00002447936,0.000002072869,0.0002152729],"genre_scores_gemma":[0.9996262,0.0000629199,0.00003859035,0.00004206478,0.000007191248,0.000006443317,0.00007362967,8.213552e-7,0.0001421582],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001131712,"threshold_uncertainty_score":0.003785968,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2020402888048956,"score_gpt":0.4063018138214152,"score_spread":0.2042615250165197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}